IDEAYA Biosciences ( (IDYA) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
IDEAYA Biosciences’ stock is experiencing upward movement due to strong buy ratings from analysts, driven by promising developments in its pipeline. Key factors include the positive outlook for Darovasertib in treating uveal melanoma and advancements in the IDE849 study targeting DLL3-expressing tumors. Despite an increased quarterly net loss of $77.49 million compared to last year’s $52.77 million, analysts remain optimistic about the stock’s future growth, reflected in the consensus price target.
More about IDEAYA Biosciences
YTD Price Performance: 10.06%
Average Trading Volume: 1,180,067
Technical Sentiment Signal: Buy
Current Market Cap: $2.43B
For further insights into IDYA stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.